S. Birkenhake
About
In The Last Decade
S. Birkenhake
19 papers receiving 401 citations
Peers
Comparison fields: 5 of 64
- Surgery 238
- Urology 98
- Molecular Biology 83
- Cancer Research 75
- Oncology 72
Countries citing papers authored by S. Birkenhake
This map shows the geographic impact of S. Birkenhake's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Birkenhake with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Birkenhake more than expected).
Fields of papers citing papers by S. Birkenhake
This network shows the impact of papers produced by S. Birkenhake. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Birkenhake. The network helps show where S. Birkenhake may publish in the future.
Co-authorship network of co-authors of S. Birkenhake
This figure shows the co-authorship network connecting the top 25 collaborators of S. Birkenhake. A scholar is included among the top collaborators of S. Birkenhake based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Birkenhake. S. Birkenhake is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 85 | |
| 2 | 24 | |
| 3 | The age correction of survival probabilities in cancer studies | 4 |
| 4 | 12 | |
| 5 | 127 | |
| 6 | 6 | |
| 7 | 1 | |
| 8 | Increased radiosensitivity in ataxia-telangiectasia patients (A-T), A-T heterozygotes and cancer patients | 2 |
| 9 | 42 | |
| 10 | 6 | |
| 11 | 4 | |
| 12 | [Hypoxyradiotherapy: changes in the oxygen partial pressure distribution in the tumor and in the healthy tissue under acute respiratory hypoxia]. | 3 |
| 13 | 32 | |
| 14 | 3 | |
| 15 | [Extended reversible global left ventricular contraction dysfunction with symptomless coronary system as effect of cytostatic therapy with 5-fluorouracil]. | 4 |
| 16 | 28 | |
| 17 | 11 | |
| 18 | 2 | |
| 19 | 15 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.